Clinical and Applied Thrombosis/Hemostasis (Aug 2024)

Study on the Mutation of FⅨ Gene in 31 Patients with Type B Hemophilia

  • Danjuan Liu M.D.,
  • Rongjie Guo PhD,
  • Min Chen M.D.,
  • Bingbing Shi M.D.,
  • Junting Weng PhD,
  • Zhifang Fu M.D

DOI
https://doi.org/10.1177/10760296241275454
Journal volume & issue
Vol. 30

Abstract

Read online

Hemophilia B (HB) is an inherited bleeding disorder caused by defects in the FⅨ gene, leading to severe coagulation dysfunction. This study designed eight pairs of primers covering eight exons of the FⅨ gene and used PCR and DNA sequencing to detect FⅨ gene mutations in 31 HB patients. Sequencing results were compared with normal sequences using Chromas software on Blast to identify mutation sites. Findings revealed the CpG dinucleotide region as a mutation hotspot and the 192nd nucleotide (FⅨ192) as a dinucleotide polymorphism site in the Chinese population. Pathogenic mutations included point mutations, deletions, insertions, and mutations affecting amino acids or splicing sites. For cases with only polymorphic sites, further exon sequencing is needed. This study adds new mutation data to the global HB database, supports research on racial differences in FⅨ gene mutations, and contributes to domestic HB statistics. The results aid in understanding the FⅨ gene's role in coagulation, elucidating HB pathogenesis, and providing a basis for future gene therapy.